Menu
Primary Diagnosis
USE CASE
Diagnose causation of acute lower respiratory infections, such as Community Acquired Pneumonia and Exacerbations in patients with Chronic Respiratory Disease.
ADVANTAGES
Providing a sample from the site of infection, allowing for diagnostic results within the "golden" hour, enabling directed therapy in a timely fashion.
VALIDATION
Proof-of-Concept study 2019; Assessment of COPD patients admitted to the hospital with an exacerbation.
The Clinical Sample of Choice for Diagnosing Lung Infections
Better sample, lower burden!
USE CASE
Early detection of respiratory pathogens in patients with Chronic Respiratory Disease, e.g. CF and COPD.
ADVANTAGES
Easy-of-use and low sampling burden allow for daily or even hourly sampling, enabling health monitoring of the lower respiratory tract and early treatment, avoiding under- or over-treatment and herewith exacerbations.
VALIDATION
Early causation in CF patients; Published in Journal of Breath Research, 2022.
Health Monitoring
Unambiguous Diagnosis is Hampered by Conventional Sampling Methods
Better sample, lower burden!
Contagiousness
USE CASE
More relevant than ever, safeguarding medical personnel and determining if a patient should be isolated or can go home to recover.
ADVANTAGES
The presence of pathogens, e.g. Mycobacterium tuberculosis or SARS-COV-2, does not determine contagiousness, bio-loaded aerosols do.
VALIDATION
Determining contagiousness of COVID-19 patients by sampling exhaled breath; Published in Scientific Reports, 2022.
Get In touch
Leave us a message
Reinier Postlaan 2, 6525GC Nijmegen, The Netherlands
About
Xheal Diagnostics B.V. is a start-up company and spin-off of the Radboudumc focussed sampling innovations for the lower respiratory tract. Our proprietary exhaled breath sampling technology enables a timely and better diagnosis of lung infections and hence improves patient care.